X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
ASTRAZENECA PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 381.0%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 381.0%
Tue, 12 Feb

ASTRAZENECA PHARMA has announced its results for the quarter ended December 2018. Here is a detailed performance review of the same:

ASTRAZENECA PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Dec-17*
3
Sep-18*
3
Dec-18*
QoQ ChangeYoY Change
Net SalesRs m1,2851,6142,15233.4%67.4%
Other incomeRs m2734354.2%29.2%
TurnoverRs m1,3121,6472,18732.8%66.6%
ExpensesRs m1,3941,4661,74318.9%25.1%
Gross profitRs m-108148409176.9%
DepreciationRs m3737382.9%1.4%
InterestRs m0000.0%0.0%
Profit before taxRs m-118144406181.1%
TaxRs m-1553115116.5%
Profit after taxRs m-10491291218.6%
Gross profit margin%-8.49.119.0
Effective tax rate%12.436.828.3
Net profit margin%-7.95.513.3
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 67.4% on a year-on-year (YoY) basis. The expenses were up by 25.1% YoY during the same period.
  • The company's operating profit declined by 478.8% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 19.0% in 3QFY19 as against 8.4% in 3QFY18.
  • Depreciation charges increased by 1.4% and finance costs increased by 0.0% YoY, respectively.
  • Other income increased by 29.2% YoY during the quarter.
  • Net profit for the quarter increased by 381.0% YoY. Net profit margins during the quarter increased from -7.9% in 3QFY18 to 13.3% in 3QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 33.4% on a quarter-on-quarter (QoQ) basis. The expenses were up by 18.9% QoQ during the same period.
  • The company's operating profit increased by 176.9% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 19.0% in 3QFY19 as against 9.1% in 2QFY18.
  • Net profit for the quarter increased by 218.6% QoQ, while net profit margins increased from 5.5% in 2QFY18 to 13.3% in 3QFY19.

To see how ASTRAZENECA PHARMA has performed over the last eight quarters, please visit here.

ASTRAZENECA PHARMA Share Price Performance

Over the last one year, ASTRAZENECA PHARMA share price has moved up from Rs 1,050.4 to Rs 1,847.0, registering a Gain of Rs 796.6 or around 75.8%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,718.3 (down 0.0%). Over the last one year it has moved down from 14,517.2 to 13,718.3, a gain of 799 points (down 5.5%).

Overall, the S&P BSE SENSEX is up 6.1% over the year.

Current Valuations

At the current price of Rs 1,847.0, the price to earnings (P/E) ratio of ASTRAZENECA PHARMA stands at 96.5 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 26.9 times.

Equitymaster requests your view! Post a comment on "ASTRAZENECA PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 381.0%". Click here!

  

Related Views on News

ASTRAZENECA PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Mar 29, 2019 | Updated on Mar 29, 2019

Here's an analysis of the annual report of ASTRAZENECA PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ASTRAZENECA PHARMA. Also includes updates on the valuation of ASTRAZENECA PHARMA.

ASTRAZENECA PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 66.7% (Quarterly Result Update)

Nov 27, 2018 | Updated on Nov 27, 2018

For the quarter ended September 2018, ASTRAZENECA PHARMA has posted a net profit of Rs 91 m (down 66.7% YoY). Sales on the other hand came in at Rs 2 bn (down 1.8% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 10.3% (Quarterly Result Update)

Aug 21, 2018 | Updated on Aug 21, 2018

For the quarter ended June 2018, ASTRAZENECA PHARMA has posted a net profit of Rs 64 m (up 10.3% YoY). Sales on the other hand came in at Rs 2 bn (up 25.7% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My Top 7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

May 16, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

3 Stocks to Bet on to Become a 'Dividend Millionaire'(Profit Hunter)

May 14, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

Indian Steel: The Perfect Multibagger Opportunity(Profit Hunter)

May 17, 2019

A structurally strong Indian Steel Industry will help India achieve 8%+ GDP growth in the coming years.

What Makes TVS Srichakra and CCL Products a Cut Above the Rest?(The 5 Minute Wrapup)

May 17, 2019

Despite the commodity nature of their businesses, these two stocks have rewarded shareholders well.

The Bitter Pill that Will Lay the Foundation for Sensex 100,000(The 5 Minute Wrapup)

May 14, 2019

These companies will help the Sensex more than double from current levels.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ASTRAZENECA PHARMA SHARE PRICE


May 24, 2019 (Close)

TRACK ASTRAZENECA PHARMA

  • Track your investment in ASTRAZENECA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ASTRAZENECA PHARMA

ASTRAZENECA PHARMA - CIPLA COMPARISON

COMPARE ASTRAZENECA PHARMA WITH

MARKET STATS